Compounds > fluorodopa f 18

Page last updated: 2024-08-24

fluorodopa f 18 and Disease Models, Animal

fluorodopa f 18 has been researched along with Disease Models, Animal in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (63.64)	29.6817
2010's	4 (36.36)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, CW; Chen, TW; Chen, YR; Chung, YH; Farn, SS; Huang, YC; Tien, SW; Yeh, CN; Yu, CS	1
Hijioka, M; Inden, M; Inubushi, T; Kitamura, Y; Morikawa, S; Oda, K; Taniguchi, T; Tooyama, I; Yanagisawa, D	1
Bahri, MA; Becker, G; Garraux, G; Hustadt, F; Lemaire, C; Luxen, A; Michel, A; Plenevaux, A	1
Kiesewetter, DO; Kvetnansky, R; Lai, EW; Martiniova, L; Merino, MJ; Pacak, K; Seidel, J; Thomasson, D	1
Dinelle, K; Farrer, MJ; Holden, JE; Kornelsen, R; Mah, C; McCormick, S; Sossi, V; Stoessl, AJ; Walker, MD	1
Bergman, J; Eskola, O; Forsback, S; Grönroos, T; Haapalinna, A; Haaparanta, M; Marjamäki, P; Niemi, R; Rinne, J; Solin, O	1
Bauer, R; Brust, P; Fritz, H; Füchtner, F; Hinz, R; Kuwabara, H; Müller, M; Walter, B; Zwiener, U	1
Allen, RC; Cornfeldt, ML; Doudet, DJ; Honey, CR; Schweikert, AW	1
Chang, CW; Chen, JC; Chou, KL; Chou, YT; Lin, MT; Liu, RS	1
Aebischer, P; Bloch, J; Brown, WD; Carvey, P; Chen, EY; Chu, Y; Déglon, N; Emborg, ME; Hantraye, P; Holden, JE; Kordower, JH; Leventhal, L; Ling, Z; Ma, SY; McBride, J; Palfi, S; Pyzalski, R; Roitberg, BZ; Taylor, MD; Trono, D	1
Barrio, JR; Delanney, LE; Delfani, K; Farahani, KF; Huang, SC; Irwin, I; Janson, AM; Langston, JW; Milonas, C; Phelps, ME; Satyamurthy, N; Shoghi-Jadid, K; Stout, DB; Togasaki, DM; Yee, RE	1

Other Studies

11 other study(ies) available for fluorodopa f 18 and Disease Models, Animal

Article	Year
Synthesis and evaluation of Drug design, development and therapy, 2018, Volume: 12 Topics: Animals; Celecoxib; Cholangiocarcinoma; Cyclooxygenase 2; Dihydroxyphenylalanine; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Molecular Structure; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley	2018
Fluorodopa is a Promising Fluorine-19 MRI Probe for Evaluating Striatal Dopaminergic Function in a Rat Model of Parkinson's Disease. Journal of neuroscience research, 2017, Volume: 95, Issue:7 Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Fluorine; Fluorine Radioisotopes; Fluorine-19 Magnetic Resonance Imaging; Male; Parkinson Disease; PC12 Cells; Rats; Rats, Wistar	2017
Comparative assessment of 6-[ Journal of neurochemistry, 2017, Volume: 141, Issue:4 Topics: Animals; Apomorphine; Aromatic-L-Amino-Acid Decarboxylases; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Fluorine Radioisotopes; Image Processing, Computer-Assisted; Male; Neostriatum; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Presynaptic; Stereotyped Behavior; Tyrosine	2017
Animal model of metastatic pheochromocytoma: evaluation by MRI and PET. Endocrine regulations, 2009, Volume: 43, Issue:2 Topics: Adrenal Gland Neoplasms; Animals; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Female; Fluorine Radioisotopes; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Mice; Mice, Nude; Ovarian Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals	2009
In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [18F]FDOPA PET. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2013, Volume: 33, Issue:1 Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Fluorine Radioisotopes; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed	2013
Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease. Synapse (New York, N.Y.), 2004, Volume: 51, Issue:2 Topics: Amphetamine; Animals; Apomorphine; Autoradiography; Behavior, Animal; Brain; Brain Mapping; Central Nervous System Stimulants; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine Agonists; Functional Laterality; Immunohistochemistry; Levodopa; Male; Oxidopamine; Parkinson Disease; Propionates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase	2004
Age-dependent effects of severe traumatic brain injury on cerebral dopaminergic activity in newborn and juvenile pigs. Journal of neurotrauma, 2004, Volume: 21, Issue:8 Topics: Age Factors; Aging; Animals; Animals, Newborn; Aromatic-L-Amino-Acid Decarboxylases; Brain Injuries; Cerebral Cortex; Cerebrovascular Circulation; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Energy Metabolism; Female; Glucose; Oxygen Consumption; Positron-Emission Tomography; Sus scrofa; Up-Regulation	2004
PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease. Experimental neurology, 2004, Volume: 189, Issue:2 Topics: Animals; Binding, Competitive; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Female; Humans; Macaca fascicularis; Macaca mulatta; Male; Parkinsonian Disorders; Pigment Epithelium of Eye; Putamen; Raclopride; Radioligand Assay; Recovery of Function; Tomography, Emission-Computed; Treatment Outcome; Up-Regulation	2004
Dopamine overload visualized in the basal ganglia of rabbit brain during heatstroke can be suppressed by hypothermia. Neuroscience letters, 2005, Feb-28, Volume: 375, Issue:2 Topics: Animals; Basal Ganglia; Blood Pressure; Body Temperature; Cerebellum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Heat Stroke; Hypotension; Hypothermia, Induced; Male; Positron-Emission Tomography; Rabbits	2005
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (New York, N.Y.), 2000, Oct-27, Volume: 290, Issue:5492 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Antigens, CD; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Female; Gene Expression; Genetic Therapy; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Lentivirus; Macaca mulatta; Neostriatum; Nerve Degeneration; Nerve Growth Factors; Nerve Tissue Proteins; Neurons; Parkinson Disease; Parkinsonian Disorders; Psychomotor Performance; Substantia Nigra; Tyrosine 3-Monooxygenase	2000
Novel observations with FDOPA-PET imaging after early nigrostriatal damage. Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Female; Fluorine Radioisotopes; Male; Neural Pathways; Neurotoxins; Parkinsonian Disorders; Saimiri; Substantia Nigra; Tomography, Emission-Computed	2001